The drugmaker Novo Nordisk is slated to report its second-quarter financial results early Wednesday, after shares plunged ...

Shares in AMD took a hit and were about 6% lower in pre-market trading after the US chipmaker reported mixed quarterly earnings that missed Wall Street forecasts for adjusted earnings per share, but ...

Global stock markets and U.S. stock futures rose after a slightly lower close on Wall Street on Tuesday, while the U.S. dollar remained under pressure as expectations build for a potential Federal ...

No revenue reported as Terns remains a clinical-stage, pre-commercial biotech. A strong cash position of $315.4 million as of Q2 2025 is expected to fund operations into 2028.